<DOC>
<DOCNO>EP-0632017</DOCNO> 
<TEXT>
<INVENTION-TITLE>
N-phenyl-2-cyano-3-hydroxy propenamides, their tautomeres and salts, their use as medicaments and compositions containing them
</INVENTION-TITLE>
<CLASSIFICATIONS>C07C25554	C07C25560	A61P2900	C07C31119	C07C31100	C07C25300	A61K31275	C07C31146	C07C25330	A61K31275	C07C25520	C07C25530	C07C25558	A61P2900	C07C25500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07C	C07C	A61P	C07C	C07C	C07C	A61K	C07C	C07C	A61K	C07C	C07C	C07C	A61P	C07C	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07C255	C07C255	A61P29	C07C311	C07C311	C07C253	A61K31	C07C311	C07C253	A61K31	C07C255	C07C255	C07C255	A61P29	C07C255	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to the products of formula (I): 
<
IMAGE
>
  in which:     - R1 represents alkyl, cycloalkyl, alkenyl or alkynyl (-
>
 6c),   - R2 represents H or alkyl (-
>
 3c), - Y represents -NR3-, -SO2-NR3-, -NR3-SO2-, -CHOH-, -CF2-, -(CH2 )m-,   
<
IMAGE
>
  - C IDENTICAL C-, 
<
IMAGE
>
 with Z1 and Z2 representing H, alkyl (-
>
 3c), halogen, CN or NO2, R3 representing H or alkyl (-
>
 3c) and m = 0 to 6, - R4, R5, R6, R7 and R8 representing H, halogen, CN, NO2, alkyl, cycloalkyl, alkoxy, alkylthio (-
>
 6c), -(CH2)n-CX3, -O-(CH2)n-CX3, -S-(CH2)n-CX3, with n = 0 to 3 and X = halogen, or -CO-R10 with R10 = H, alkyl or cycloalkyl (-
>
 6c), or R6 and R7 together form -O-CH2-O-,   to their tautomeric forms and to their salts, and to their process of preparation and to their application as medicaments.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
HOECHST MARION ROUSSEL INC
</APPLICANT-NAME>
<APPLICANT-NAME>
HOECHST MARION ROUSSEL
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
KUO ELIZABETH ANNE
</INVENTOR-NAME>
<INVENTOR-NAME>
KUO, ELIZABETH ANNE
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
N-(phenyl)-2-cyano-3-hydroxy-propenamides corresponding 
to general formula (I): 


 
in which: 


R
1
 represents a cycloalkl radical containing 3 to 6 carbon 
atoms, 
R
2
 represents a hydrogen atom, an alkyl radical containing 
from 1 to 3 carbon atoms, 
Y represents a group:
 
-NR
3
- , -SO
2
-NR
3
- , -NR
3
-SO
2
- , -CHOH- , -CF
2
- , -(CH
2
)
m
-, 

 
groups in which Z
1
 and Z
2
, identical or different, represent a 
hydrogen atom, a halogen atom, an alkyl radical containing 

from 1 to 3 carbon atoms, a -CN group, an NO
2
 group, R
3
 
represents a hydrogen atom or an alkyl radical containing 

from 1 to 3 carbon atoms, m is an integer which can vary from 
0 to 6,  

 
R
4
, R
5
, R
6
, R
7
 and R
8
, which may be identical or different, 
represent a hydrogen atom, a halogen atom, a -CN group, an - 

NO
2
 group, a linear or branched alkyl radical containing from 
1 to 6 carbon atoms, a cycloalkyl radical containing from 3 

to 6 carbon atoms, a linear or branched alcoxy radical 
containing from 1 to 6 carbon atoms, an alkylthio radical 

containing from 1 to 6 carbon atoms, a -(CH
2
)
n
-CX
3
 radical, an 
-O-(CH
2
)
n
-CX
3
 radical a -S-(CH
2
)
n
-CX
3
 radical, in which radicals 
n represent an integer comprised between 0 and 3 and X 

represents a halogen atom, or a - CO - R
10
 group in which R
10
 
represents a hydrogen atom, a linear or branched alkyl 

radical containing from 1 to 6 carbon atoms, a cycloalkyl 
containing from 3 to 6 carbon atoms,
 
or R
6
 and R
7
 together form a -O-CH
2
-O- group, and R
4
, R
5
 and R
8
 
have the definition indicated above, their tautomeric forms, 

and their addition salts with mineral or organic bases. 
N-(phenyl) 2-cyano-3-hydroxy-propenamides, as defined in 
formula (I) of claim 1, characterized in that in said formula 

(I), 

R
1
 represents a cyclopropyl radical, Y, R
2
, R
4
, R
5
, R
6
, R
7
 and 
R
8
 have the meaning already indicated, their tautomeric forms 
as well as their addition salts with mineral or organic 

bases. 
N-(phenyl) 2-cyano-3-hyrdoxy-propenamides, corresponding 
to formula (I) according to claim 1 or 2, characterized in 

that in said formula (I), R2 represents a hydrogen atom or a 
methyl radical and R
1
, Y, R
4
, R
5
, R
6
, R
7
 and R
8
 have the meaning 
already indicated, their tautomer forms and their addition 

salts with mineral or organic bases. 
N-(phenyl) 2-cyano-3-hydroxy-propenamides corresponding 
to formula (I) according to any one of claims 1, 2 and 3, 

characterized in that in said formula (I), 

R
1
 represents a cyclopropyl radical, 
R
2
 represents a hydrogen atom or a methyl radical,  
 
Y represents a -(CH
2
)
m
- group in which m is equal to 0, 1 or 2 
or a group: 


 
and either R
4
, R
5
, R
6
, R
7
 and R
8
, identical or different, 
represent a hydrogen atom, a chlorine, bromine or fluorine 

atom, a -CN group, an -NO
2
 group, a methyl radical, a 
cyclopropyl radical, a methoxy radical, a methylthio radical, 

a -(CH
2
)
n
-CF
3
 radical, an -O-(CH
2
)
n
-CF
3
 radical, an -S-(CH
2
)
n
-CF
3
 
radical, in which radicals n represents an integer comprised 

between 0 and 3 or a - CO - R
10
 group in which R
10
 represents a 
hydrogen atom, a methyl radical, a cyclopropyl radical, or R
6
 
and R
7
, together form a 6,7-O-CH
2
-O- group and R
4
, R
5
 and R
8
 
have the meaning indicated in claim 1, their tautomeric forms 

as well as their addition salts with mineral or organic 
bases. 
N-(phenyl) 2-cyano-3-hydroxy-propenamides corresponding 
to formula (I) according to any one of claims 1, 2, 3 and 4, 

characterized in that in said formula (I), 

R
1
 represents a cyclopropyl radical, R
2
 represents a hydrogen 
atom or a methyl radical,  

 
Y represents a -(CH
2
)
m
- group in which m is equal to 0, 1 or 2 
or a group: 


R
4
, R
5
, R
6
, R
7
 and R
8
 , identical or different, represent a 
hydrogen atom, a chlorine, bromine or fluorine atom, an - NO
2
 
group, a methyl radical or a -CF
3
 radical, their tautomeric 
forms, as well as their addition salts with the mineral or 

organic bases. 
N-phenyl 2-cyano-3-hydroxy-propenamides corresponding to 
formula (I) according to any one of claims 1 to 5 the names 

of which follow: 

N-[4-(4'-chlorophenyl-E-ethenyl) phenyl] 2-cyano 3-cyclopropyl 

3-hydroxy-prop-2-enamide, 
N-[4-(4'-fluorophenyl-E-ethenyl) phenyl] 2-cyano 3-cyclopropyl 

3-hydroxy-prop-2-enamide, 
N-[4-biphenylyl] 2-cyano 3-cyclopropyl 3-hydroxy-prop-2-enamide, 
N-[4-(4'-fluorophenyl) phenyl] 2-cyano 3-cyclopropyl 3-hydroxy-prop-2-enamide,
 
as well as their addition salts with mineral or organic 

bases. 
Process for the preparation of N-phenyl 2-cyano-3-hydroxy-propenamides 
as defined in formula (I) of claim 1, as 

well as their salts, characterized in that a product of 
formula (II):  

 

 
in which R
2
, Y, R
4
, R
5
, R
6
, R
7
 and R
8
, have the meaning already 
indicated in claim 1, is reacted successively with sodium 

hydride, if necessary in the presence of a catalyst, then the 
product is reacted with the functional derivative of an acid 

of formula (III): 

 
in which Hal represents a halogen atom and R
1
 has the meaning 
already indicated in claim 1, in order to obtain a 

corresponding product of formula (I) which is isolated and if 
desired salified or reacted with a functional derivative of 

an acid of formula (III
A
): 

 
in which Hal represents a halogen atom and R
A
 represents a 
duly protected R
1
 radical, in order to obtain a product of 
formula (I
A
):  
 


 
in which R
A
, R
2
, Y, R
4
, R
5
, R
6
, R
7
 and R
8
 have the meaning 
already indicated, the product of formula (I
A
) thus obtained 
in which R
A
 has the meaning already indicated is deprotected 
in order to obtain a corresponding product of formula (I), 

which is isolated and if desired salified. 
Preparation process according to claim 7, characterized 
in that the reaction of the product of formula (II) with 

sodium hydride is carried out in the presence of imidazole, 
in an anhydrous organic solvent such as tetrahydrofuranne or 

dichloromethane. 
Preparation process according to claim 7 or 8, 
characterized in that the reaction with the functional 

derivative of the acif of formula (III) or (III
A
) is carried 
out at low temperature or at ambient temperature, in the 

presence of imidazole within an anhydrous organic solvent 
such as tetrahydrofuran or dichloromethane. 
Preparation process according to any one of claims 7 to 
9, characterized in that in the compound of formula (III
A
), R
A
 
represents an R
1
 radical protected by an arylseleno group, 
preferably a phenylseleno radical. 
Preparation process according to any one of claims 7 to 
10, characterized in that the product of formula (II) is 

prepared by reacting a product of formula (IV):  
 


 
in which Y, R
4
, R
5
, R
6
, R
7
 and R
8
 have the meaning indicated in 
claim 7 with cyanoacetic acid. 
Preparation process according to claim 11, characterized 
in that the reaction of the compound of formula (IV) with 

cyanoacetic acid is carried out in the presence of 
dicyclocarbodiimide or phosphorus pentachloride in an 

anhydrous organic solvent such as tetrahydrofuran or 
dichloromethane. 
Preparation process according to claim 11 or 12, 
characterized in that the compound of formula (IV) is 

prepared by the reduction of the corresponding nitro product 
of formula (V): 


 
in which Y, R
4
, R
5
, R
6
, R
7
 and R
8
 have the meaning indicated in 
claim 11. 
Medicaments characterized in that they are constituted 
by N-phenyl 2-cyano-3-hydroxy-propenamides as defined in 

formula (I) of claim 1, as well as by their addition salts 
with pharmaceutically acceptable bases. 
Medicaments, characterized in that they are constituted 
by N-phenyl 2-cyano-3-hydroxy-propenamides as defined in any 

one of claims 2 to 6, as well as their addition salts with  
 

pharmaceutically acceptable bases. 
Pharmaceutical compositions, characterized in that they 
contain as active ingredient at least one of the medicaments 

as defined in any one of claims 14 and 15. 
</CLAIMS>
</TEXT>
</DOC>
